2-phenylindole has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbar, Z; Harris, F; Karakoula, K; Lea, R; Prabhu, S; Rowther, F; Snape, T; Warr, T | 1 |
| Rowther, F; Sherer, C; Snape, TJ; Tolaymat, I; Warr, T | 1 |
2 other study(ies) available for 2-phenylindole and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Preliminary biological evaluation and mechanism of action studies of selected 2-arylindoles against glioblastoma.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Survival; Cisplatin; Glioblastoma; Humans; Indoles; Inhibitory Concentration 50; Reactive Oxygen Species | 2013 |
Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Indoles; Structure-Activity Relationship | 2017 |